Lei-Lei Ma

Lei-Lei Ma

Auto-generated profile, based on publicly available information

Lei-Lei Ma

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
HLHaibo Liu
Haibo Liu
WGWei Gao
Wei Gao
JYJie Yuan
Jie Yuan
CWChaoneng Wu
Chaoneng Wu
KYKang Yao
Kang Yao
JGJunbo Ge
Junbo Ge

20 December 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JGJunjie Guo
Junjie Guo
LMLei-Lei Ma
Lei-Lei Ma
HSHong-Tao Shi
Hong-Tao Shi
JZJian-Bing Zhu
Jian-Bing Zhu
JWJian Wu
Jian Wu
JGJunbo Ge
Junbo Ge
Doxorubicin (DOX) is a highly potent chemotherapeutic agent, but its usage is limited by dose-dependent cardiotoxicity. DOX-induced cardiotoxicity involves increased oxidative stress and activated endoplasmic reticulum-mediated apoptosis. Alginate oligosaccharide (AOS) is a non-immunogenic, non-toxic and biodegradable polymer, with anti-oxidative, anti-inflammatory and anti-endoplasmic reticulum stress properties. The present study examined whether AOS pretreatment could protect against acute DOX cardiotoxicity, and the underlying mechanisms focused on oxidative stress and endoplasmic reticulum-mediated apoptosis. We found that AOS pretreatment markedly increased the survival rate of mice insulted with DOX, improved DOX-induced cardiac dysfunction and attenuated DOX-induced myocardial apoptosis. AOS pretreatment mitigated DOX-induced cardiac oxidative stress, as shown by the decreased expressions of gp91 (phox) and 4-hydroxynonenal (4-HNE). Moreover, AOS pretreatment significantly decreased the expression of Caspase-12, C/EBP homologous protein (CHOP) (markers for endoplasmic reticulum-mediated apoptosis) and Bax (a downstream molecule of CHOP), while up-regulating the expression of anti-apoptotic protein Bcl-2. Taken together, these findings identify AOS as a potent compound that prevents acute DOX cardiotoxicity, at least in part, by suppression of oxidative stress and endoplasmic reticulum-mediated apoptosis.

28 October 2016 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
FKFei-Juan Kong
Fei-Juan Kong
LMLei-Lei Ma
Lei-Lei Ma
SCShu-Ping Chen
Shu-Ping Chen
GLGe Li
Ge Li
JZJia-Qiang Zhou
Jia-Qiang Zhou
The association between serum selenium level and gestational diabetes mellitus (GDM) is controversial. The aim of our study was to systematically review available literature linking selenium to GDM for a comprehensive understanding of the relationship between serum selenium level and GDM in human. PubMed, The Cochrane Library and Medline were searched for studies published up to August 2016. Manual searches of references of the relevant original studies were carried out. Pooled estimates were measured using the fixed or random effect model. Overall effect was reported in a standard mean difference (SMD). All data were analyzed with Review Manager 5.3 and Stata 12.0. Of 44 references reviewed, seven studies involving 569 patients met our inclusion criteria and contributed to meta-analysis. All the studies were used to evaluate the relationship between serum selenium level and GDM. Selenium level was significantly lower in women with GDM than those without GDM (SMD = −1.17; 95 % CI: −1.98 to −0.35, P = 0.005). Subgroup analysis showed that such trend was consistent within the non-Caucasian population (Asia: SMD = −2.82; 95 % CI: −5.21 to −0.43, P = 0.02; Africa: SMD = −0.56; 95 % CI: −1.07 to −0.05, P = 0.03) and in the third trimester (SMD = −1.78; 95 % CI: −3.04 to −0.52, P = 0.006), but not within the Caucasian population (Europe: SMD = −0.6; 95 % CI: −1.98 to 0.78, P = 0.39) or in the second trimester (SMD = −0.68; 95 % CI: −1.6 to 0.25, P = 0.15). The available evidences suggested that serum selenium level was lower in women with GDM than those with normal glucose tolerance, especially within the non-Caucasian population and in the third trimester. However, well-designed prospective studies are needed to understand dynamic associations between selenium status and GDM risk.

4 September 2024 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
JWJian-Ping Wu
Jian-Ping Wu
CWCheng Wu
Cheng Wu
YMYuan-Ji Ma
Yuan-Ji Ma
JZJian-Bing Zhu
Jian-Bing Zhu
LMLei-Lei Ma
Lei-Lei Ma
FKFei-Juan Kong
Fei-Juan Kong

26 December 2024 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Open access
PDF file
JWJian-Ping Wu
Jian-Ping Wu
CWCheng Wu
Cheng Wu
YMYuan-Ji Ma
Yuan-Ji Ma
JZJian-Bing Zhu
Jian-Bing Zhu
LMLei-Lei Ma
Lei-Lei Ma
FKFei-Juan Kong
Fei-Juan Kong

6 February 2025 in Medical Engineering & Physics
Verified
Journal Article
Closed access
LMLeilei Ma
Leilei Ma
ZWZhe Wang
Zhe Wang
JYJiaqi Yang
Jiaqi Yang
BSBin Shen
Bin Shen
Yao LiuYao Liu
Yao Liu
JGJunbo Ge
Junbo Ge
A coronary atherectomy system (CAS) was developed with a novel burr designed for a two-phase atherectomy procedure: low-speed drilling for lesion crossing and high-speed orbiting to achieve luminal gain, to removal the stenosis in artery. To investigate the CAS mechanism and validate its efficacy and safety. Engineering bench-top testings were conducted to evaluate the burr crossing time, luminal gain, debris size, temperature rise, and grinding force together with in-vivo and ex-vivo swine studies. The bench-top engineering testing results showed that the CAS can expand the calcified lumen diameter from 0.4 to 1.7 mm and the debris size, temperature rise, and grinding force were relatively low and safe. In the in-vivo swine study, the media and internal elastic membrane remained intact. The intima of the artery was removed at the 0-day follow-up and re-growthed at the 30-day follow-up. No abnormal phenomenon in the digital subtraction angiography, blood testing, ECG, and anatomy analysis were found. The ex-vivo study, by inserting a plaque surragate (graphite) into the coronary artery, showed similar efficacy in luminal gain and safety. This study demonstrated the efficacy and safety of CAS device with the novel two-phase burr design.